We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
2 hedge funds and large institutions have $12.8K invested in Windtree Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more ownership
Funds ownership: 0% → 0% (+0%)
87% less funds holding
Funds holding: 15 → 2 (-13)
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 14
95% less capital invested
Capital invested by funds: $279K → $12.8K (-$266K)
Holders
2
Holders Change
-13
Holders Change %
-86.67%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.7K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$57K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$36.1K |
| 3 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$31.8K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$28.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$26K |
